Keros Therapeutics, Inc. (KROS): 10-Q filed Aug 3, 2026

Form type

10-Q

Filing date

Aug 3, 2026

Accession number

0001664710-26-000049

Filer

Keros Therapeutics, Inc. (CIK 1664710)